Orr, Jeremy E., Erica C. Heinrich, Matea Djokic, Dillon Gilbertson, Pamela N. Deyoung, Cecilia Anza-Ramirez, Francisco C. Villafuerte, Frank L. Powell, Atul Malhotra, and Tatum Simonson. Adaptive servoventilation as treatment for central sleep apnea due to high-altitude periodic breathing in nonacclimatized healthy individuals. High Alt Med Biol. 19:178-184, 2018. AIMS: Central sleep apnea (CSA) is common at high altitude, leading to desaturation and sleep disruption. We hypothesized that noninvasive ventilation using adaptive servoventilation (ASV) would be effective at stabilizing CSA at altitude. Supplemental oxygen was evaluated for comparison. METHODS:Healthy subjects were brought from sea level to 3800 m and underwent polysomnography on three consecutive nights. Subjects underwent each condition-No treatment, ASV, and supplemental oxygen-in random order. The primary outcome was the effect of ASV on oxygen desaturation index (ODI). Secondary outcomes included oxygen saturation, arousals, symptoms, and comparison to supplemental oxygen. RESULTS:Eighteen subjects underwent at least two treatment conditions. There was a significant difference in ODI across the three treatments. There was no statistical difference in ODI between no treatment and ASV (17.1 ± 4.2 vs. 10.7 ± 2.9 events/hour; p > 0.17) and no difference in saturation or arousal index. Compared with no treatment, oxygen improved the ODI (16.5 ± 4.5 events/hour vs. 0.5 ± 0.2 events/hour; p < 0.003), in addition to saturation and arousal index. CONCLUSIONS: We found that ASV was not clearly efficacious at controlling CSA in persons traveling to 3800 m, whereas supplemental oxygen resolved CSA. Adjustment in the ASV algorithm may improve efficacy. ASV may have utility in acclimatized persons or at more modest altitudes.
RCT Entities:
Orr, Jeremy E., Erica C. Heinrich, Matea Djokic, Dillon Gilbertson, Pamela N. Deyoung, Cecilia Anza-Ramirez, Francisco C. Villafuerte, Frank L. Powell, Atul Malhotra, and Tatum Simonson. Adaptive servoventilation as treatment for central sleep apnea due to high-altitude periodic breathing in nonacclimatized healthy individuals. High Alt Med Biol. 19:178-184, 2018. AIMS: Central sleep apnea (CSA) is common at high altitude, leading to desaturation and sleep disruption. We hypothesized that noninvasive ventilation using adaptive servoventilation (ASV) would be effective at stabilizing CSA at altitude. Supplemental oxygen was evaluated for comparison. METHODS: Healthy subjects were brought from sea level to 3800 m and underwent polysomnography on three consecutive nights. Subjects underwent each condition-No treatment, ASV, and supplemental oxygen-in random order. The primary outcome was the effect of ASV on oxygen desaturation index (ODI). Secondary outcomes included oxygen saturation, arousals, symptoms, and comparison to supplemental oxygen. RESULTS: Eighteen subjects underwent at least two treatment conditions. There was a significant difference in ODI across the three treatments. There was no statistical difference in ODI between no treatment and ASV (17.1 ± 4.2 vs. 10.7 ± 2.9 events/hour; p > 0.17) and no difference in saturation or arousal index. Compared with no treatment, oxygen improved the ODI (16.5 ± 4.5 events/hour vs. 0.5 ± 0.2 events/hour; p < 0.003), in addition to saturation and arousal index. CONCLUSIONS: We found that ASV was not clearly efficacious at controlling CSA in persons traveling to 3800 m, whereas supplemental oxygen resolved CSA. Adjustment in the ASV algorithm may improve efficacy. ASV may have utility in acclimatized persons or at more modest altitudes.
Entities:
Keywords:
altitude; central sleep apnea; lung; noninvasive ventilation
Authors: Bhavneesh K Sharma; Jessie P Bakker; David G McSharry; Akshay S Desai; Shahrokh Javaheri; Atul Malhotra Journal: Chest Date: 2012-11 Impact factor: 9.410
Authors: Yvonne Nussbaumer-Ochsner; Justyna Ursprung; Christoph Siebenmann; Marco Maggiorini; Konrad E Bloch Journal: Sleep Date: 2012-03-01 Impact factor: 5.849
Authors: Fernando A Moraga; Daniel Jiménez; Jean Paul Richalet; Manuel Vargas; Jorge Osorio Journal: Respir Physiol Neurobiol Date: 2014-09-09 Impact factor: 1.931
Authors: Tsogyal D Latshang; Yvonne Nussbaumer-Ochsner; Rahel M Henn; Silvia Ulrich; Christian M Lo Cascio; Bruno Ledergerber; Malcolm Kohler; Konrad E Bloch Journal: JAMA Date: 2012-12-12 Impact factor: 56.272
Authors: Erica C Heinrich; Matea A Djokic; Dillon Gilbertson; Pamela N DeYoung; Naa-Oye Bosompra; Lu Wu; Cecilia Anza-Ramirez; Jeremy E Orr; Frank L Powell; Atul Malhotra; Tatum S Simonson Journal: PLoS One Date: 2019-06-12 Impact factor: 3.240
Authors: James J Yu; Amy L Non; Erica C Heinrich; Wanjun Gu; Joe Alcock; Esteban A Moya; Elijah S Lawrence; Michael S Tift; Katie A O'Brien; Jay F Storz; Anthony V Signore; Jane I Khudyakov; William K Milsom; Sean M Wilson; Cynthia M Beall; Francisco C Villafuerte; Tsering Stobdan; Colleen G Julian; Lorna G Moore; Mark M Fuster; Jennifer A Stokes; Richard Milner; John B West; Jiao Zhang; John Y Shyy; Ainash Childebayeva; José Pablo Vázquez-Medina; Luu V Pham; Omar A Mesarwi; James E Hall; Zachary A Cheviron; Jeremy Sieker; Arlin B Blood; Jason X Yuan; Graham R Scott; Brinda K Rana; Paul J Ponganis; Atul Malhotra; Frank L Powell; Tatum S Simonson Journal: Front Physiol Date: 2022-08-08 Impact factor: 4.755